Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Revue Maghrebine de Pediatrie [La]. 2004; 14 (2): 95-99
en Francés | IMEMR | ID: emr-205788

RESUMEN

We report a case of fetal goitrous diagnosed on ultrasonogram done at 20 weeks of gestation in a fetus whose mother was diabetic, treated with amiodarone for mitrale's prosthesis and having a child with a caudal regression syndrome. Thyroid maternal function was normal. An iodine overloading because use of amiodarone has been evoked. A medical interruption of pregnancy for mother safety was done at 25 weeks of gestation. The authors describe the ultrasonographic and biological diagnosis of goiter, their aetiology and complications and discuss the antenatal management

2.
Revue Maghrebine de Pediatrie [La]. 2004; 14 (6): 289-294
en Francés | IMEMR | ID: emr-205800

RESUMEN

Introduction: Cutaneous mastocytosis [CM] is a rare disease defined as the infiltration of the skin by mast cells. This disorder is more frequentin children. The evolution of the pediatric form to a systemic disease is rare


Patients and Methods: Our study concerned 15 children seen in the dermatology department of Charles Nicolle Hospital between 1984 and 2002. The aim of this work is to show clinic, therapeutic and evolutive particularities of this disease


Results: Sex-ratio was about 0.87 [7 males and 8 females]. The age at onset of the lesion ranged from one month to 11.5 years. Urticaria pigmentosa was observed in 11 cases, diffuse cutaneous mastocytosis in 2 cases and and xanthelasmoid form in two other children. The treatment of our patients was based essentially on preventive measures and symptomatic therapy with histamine receptor antagonists. Over a mean follow-up period of 11 months we noted regression or resolution of the lesions in 9 cases


Discussion: Urticaria pigmentosa is the most benign. However, systemic signs are more frequent in the diffuse cutaneous mastocytosis form. Preventive measures are the main therapeutic mean; especially avoidance of histamine-releasing agents

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA